Related Experiment Video

Updated: Jul 15, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness

Nicholas J Gaspar1, Lingyun Li, Ann M Kapoun

  • 1Scios Inc., Fremont, CA, USA. gaspar.nj@gmail.com

Molecular Pharmacology
|April 3, 2007
PubMed

Insights

Transforming growth factor beta (TGFbeta) signaling drives pancreatic cancer progression. Inhibiting TGFbeta receptor I kinase (TGFbetaRI) with SD-208 reduced tumor growth and metastasis in preclinical models.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Transforming growth factor beta (TGFbeta) is a key regulator of cell functions, but its pathway is often dysregulated in cancer.
  • In pancreatic cancer, TGFbeta signaling can promote tumor invasiveness, metastasis, and resistance to antiproliferative effects.
  • Targeting TGFbetaRI kinase presents a potential therapeutic strategy for pancreatic adenocarcinoma.

Purpose of the Study:

  • To investigate the efficacy of SD-208, a TGFbetaRI kinase inhibitor, in blocking TGFbeta signaling in pancreatic cancer cells.
  • To determine the impact of SD-208 on TGFbeta-regulated gene expression and cellular processes promoting tumor progression.
  • To evaluate the therapeutic potential of SD-208 in reducing tumor growth and metastasis in a preclinical pancreatic cancer model.

Main Methods:

  • Utilized PANC-1 human pancreatic tumor cells and an orthotopic xenograft mouse model.
  • Administered SD-208, an ATP-competitive inhibitor of TGFbetaRI kinase.
  • Assessed TGFbeta signaling by measuring Smad2 phosphorylation and gene expression via cDNA microarray analysis.
  • Evaluated cellular invasion using Boyden chamber assays and tumor progression in vivo.

Main Results:

  • SD-208 effectively inhibited TGFbeta-dependent Smad2 phosphorylation and TGFbeta-inducible gene expression in PANC-1 cells.
  • Gene expression analysis revealed SD-208's ability to counteract TGFbeta-driven genes involved in metastasis, angiogenesis, proliferation, survival, and apoptosis.
  • In vitro, SD-208 significantly inhibited TGFbeta-stimulated cell invasion.
  • In vivo, SD-208 treatment reduced primary tumor growth and decreased the incidence of metastasis in the orthotopic xenograft model.

Conclusions:

  • TGFbeta signaling plays a critical role in promoting pancreatic adenocarcinoma progression through various cellular mechanisms.
  • Inhibition of TGFbetaRI kinase with SD-208 effectively blocks key signaling pathways and cellular processes that drive tumor growth and metastasis.
  • Small-molecule inhibitors targeting TGFbetaRI, such as SD-208, show promise as a therapeutic strategy for treating human pancreatic cancer.

More Related Videos

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...